Advertisement
 
YOU ARE HERE: LAT HomeCollectionsSteven Rosenberg
IN THE NEWS

Steven Rosenberg

BUSINESS
January 14, 1986 | AL DELUGACH, Times Staff Writer
MGM/UA Entertainment Co. and Turner Broadcasting System said Monday that their $1.45-billion merger deal is in some trouble and that efforts are under way to salvage it. The joint statement by the Culver City movie company and the Atlanta broadcaster 80% owned by entrepreneur Ted Turner was the first official comment since The Times reported Saturday that complications apparently had developed in the deal.
Advertisement
BUSINESS
October 14, 1987 | JAMES F. PELTZ, Times Staff Writer
Wherehouse Entertainment, a leading videotape, record and computer software chain, received a surprise takeover bid Tuesday from Shamrock Holdings, which offered $113.5 million for the Wherehouse stock it does not already own. Shamrock, a Burbank-based investment company controlled by the family of Roy E. Disney, nephew of the late Walt Disney, offered $14.25 a share for Wherehouse but said it is prepared to sweeten the bid if necessary.
HEALTH
March 5, 2012 | By Melissa Healy, Los Angeles Times
In a bid to make cancer immunotherapy more effective, researchers report they have succeeded in halting the progress of aggressive melanoma in its tracks - at least briefly - in seven patients treated with an army of cloned cancer-fighting immune cells. In one of those patients, the treatment resulted in complete remission of his metastatic melanoma and evidence that his immune system stands ready to fight any return of the cancer after three years. The study, published Monday in the Proceedings of the National Academies of Science, contributes to hopes that a tumor-fighting strategy called immunotherapy can slow, halt or even reverse the growth of a range of cancers - and do so with fewer dangerous side effects.
NEWS
January 31, 1989 | MARLENE CIMONS, Times Staff Writer
A federal scientific advisory panel, which earlier this month approved the first experiments involving the transfer of genetically altered cells into humans, Monday rejected a proposal to establish an outside review committee to consider the social and ethical implications of such research.
OPINION
September 15, 1996
Since the end of the Cold War, U.S. scientists have had to knock on corporate doors for the research funds once lavished on them by a government eager to maintain American technological dominance. The resulting corporate-academic partnership has produced research projects of considerable value, but not without sometimes generating bitter conflict between scientists and business.
BUSINESS
August 10, 1989 | LARRY GREEN and TRACY SHRYER, Times Staff Writers
As their chief accuser, a one-time undercover FBI agent, quietly watched, a dozen traders and brokers accused of cheating customers pleaded innocent Wednesday. They were charged in the government's investigation of alleged fraud at Chicago's commodities exchanges, the world's largest. All 12 once traded volatile Japanese yen futures at the Chicago Mercantile Exchange, where silver-haired FBI agent Dietrich W.
BUSINESS
August 26, 1986 | DANIEL AKST, Times Staff Writer
In what appears to be the first patent suit involving gene-splicing technology, a Thousand Oaks firm is asking a federal judge to overturn the only U.S. patents issued for a promising new anti-cancer substance called interleukin-2. The suit was filed by Amgen in U.S. District Court in San Francisco against Cetus Corp., an Emeryville, Calif., firm that holds the patents. Cetus supplied the drug, also known as IL-2, used by Dr. Steven A.
ENTERTAINMENT
July 14, 1987 | JACK MATHEWS
It is Labor Day weekend, 1997. You have some neighbors coming over for the evening (they left this morning to beat the traffic), the barbecue is stoked for an early fish fry (red meat was outlawed two years ago) and your new 80-square-foot Sony high-definition television screen is putting out a picture so sharp your kid just broke his arm trying to hug a Smurf. You know you're going to end up watching TV. The question is, what are you going to watch? You have many choices.
BUSINESS
March 22, 1995 | KAREN SOUTHWICK, SPECIAL TO THE TIMES
When scientists first identified the gene that causes cystic fibrosis back in 1989, those suffering from the disease suddenly had hope. Medical researchers believed it would soon be possible to replace the gene that causes the disease--the most common fatal genetic disorder affecting Caucasians--by using the new tools of biotechnology.
ENTERTAINMENT
August 1, 1987 | JACK MATHEWS
It is both heartening and depressing to note that in the midst of the summer of '87, "Snow White and the Seven Dwarfs" is at or near the top of the box-office chart. It is heartening because it proves to any sensible reader of trends that there is a hugely lucrative market for quality family movies. It's depressing because Hollywood had to dig 50 years into its past to find one.
Los Angeles Times Articles
|